Literature DB >> 10388772

Reversible thermal denaturation of human FGF-1 induced by low concentrations of guanidine hydrochloride.

S I Blaber1, J F Culajay, A Khurana, M Blaber.   

Abstract

Human acidic fibroblast growth factor (FGF-1) is a powerful mitogen and angiogenic factor with an apparent melting temperature (Tm) in the physiological range. FGF-1 is an example of a protein that is regulated, in part, by stability-based mechanisms. For example, the low Tm of FGF-1 has been postulated to play an important role in the unusual endoplasmic reticulum-independent secretion of this growth factor. Despite the close relationship between function and stability, accurate thermodynamic parameters of unfolding for FGF-1 have been unavailable, presumably due to effects of irreversible thermal denaturation. Here we report the determination of thermodynamic parameters of unfolding (DeltaH, DeltaG, and DeltaCp) for FGF-1 using differential scanning calorimetry (DSC). The thermal denaturation is demonstrated to be two-state and reversible upon the addition of low concentrations of added guanidine hydrochloride (GuHCl). DeltaG values from the DSC studies are in excellent agreement with values from isothermal GuHCl denaturation monitored by fluorescence and circular dichroism (CD) spectroscopy. Furthermore, the results indicate that irreversible denaturation is closely associated with the formation of an unfolding intermediate. GuHCl appears to promote reversible two-state denaturation by initially preventing aggregation of this unfolding intermediate, and at subsequently higher concentrations, by preventing formation of the intermediate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388772      PMCID: PMC1300344          DOI: 10.1016/S0006-3495(99)76904-3

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  39 in total

1.  Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo.

Authors:  E G Nabel; Z Y Yang; G Plautz; R Forough; X Zhan; C C Haudenschild; T Maciag; G J Nabel
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

2.  Effect of polyanions on the unfolding of acidic fibroblast growth factor.

Authors:  C J Burke; D B Volkin; H Mach; C R Middaugh
Journal:  Biochemistry       Date:  1993-06-29       Impact factor: 3.162

3.  Nature of the interaction of heparin with acidic fibroblast growth factor.

Authors:  H Mach; D B Volkin; C J Burke; C R Middaugh; R J Linhardt; J R Fromm; D Loganathan; L Mattsson
Journal:  Biochemistry       Date:  1993-05-25       Impact factor: 3.162

4.  Formulation design of acidic fibroblast growth factor.

Authors:  P K Tsai; D B Volkin; J M Dabora; K C Thompson; M W Bruner; J O Gress; B Matuszewska; M Keogan; J V Bondi; C R Middaugh
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

5.  Enhanced revascularization of the ischemic limb by angiogenic therapy.

Authors:  L Q Pu; A D Sniderman; R Brassard; K J Lachapelle; A M Graham; R Lisbona; J F Symes
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

6.  Acidic fibroblast growth factor accelerates the healing of acetic-acid-induced gastric ulcers in rats.

Authors:  L R Fitzpatrick; A Jakubowska; G E Martin; M Davis; M C Jaye; C A Dionne
Journal:  Digestion       Date:  1992       Impact factor: 3.216

7.  Mesoderm induction in early Xenopus embryos by heparin-binding growth factors.

Authors:  J M Slack; B G Darlington; J K Heath; S F Godsave
Journal:  Nature       Date:  1987 Mar 12-18       Impact factor: 49.962

8.  Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro.

Authors:  T K Rosengart; W V Johnson; R Friesel; R Clark; T Maciag
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

9.  Growth of "new" coronary vascular structures by angiogenetic growth factors.

Authors:  K Schlaudraff; B Schumacher; B U von Specht; R Seitelberger; V Schlosser; R Fasol
Journal:  Eur J Cardiothorac Surg       Date:  1993       Impact factor: 4.191

10.  Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector.

Authors:  A Wiedlocha; I H Madshus; H Mach; C R Middaugh; S Olsnes
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  25 in total

1.  Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a beta-trefoil.

Authors:  S R Brych; S I Blaber; T M Logan; M Blaber
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Accommodation of a highly symmetric core within a symmetric protein superfold.

Authors:  Stephen R Brych; Jaewon Kim; Timothy M Logan; Michael Blaber
Journal:  Protein Sci       Date:  2003-12       Impact factor: 6.725

3.  Experimental support for the evolution of symmetric protein architecture from a simple peptide motif.

Authors:  Jihun Lee; Michael Blaber
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

4.  Evolution of a protein folding nucleus.

Authors:  Xue Xia; Liam M Longo; Mason A Sutherland; Michael Blaber
Journal:  Protein Sci       Date:  2015-12-10       Impact factor: 6.725

5.  Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.

Authors:  Vikash Kumar Dubey; Jihun Lee; Michael Blaber
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

6.  An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Jae Myoung Suh; Annette R Atkins; Michael Downes; Ronald M Evans; Connie A Tenorio; Ewa Bienkiewicz; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-10-20       Impact factor: 3.534

7.  Simplified protein design biased for prebiotic amino acids yields a foldable, halophilic protein.

Authors:  Liam M Longo; Jihun Lee; Michael Blaber
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

8.  Alternative type I and I' turn conformations in the beta8/beta9 beta-hairpin of human acidic fibroblast growth factor.

Authors:  Jaewon Kim; Sachiko I Blaber; Michael Blaber
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

9.  Expression of pro- and anti-angiogenic factors during the formation of the periocular vasculature and development of the avian cornea.

Authors:  Sam Kwiatkowski; Ravi P Munjaal; Teresa Lee; Peter Y Lwigale
Journal:  Dev Dyn       Date:  2013-04-24       Impact factor: 3.780

10.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.